Related Experiment Video
Updated: Aug 13, 2026

Diagnosis of Hirschsprung's Disease by Immunostaining Rectal Suction Biopsies for Calretinin, S100 Protein and Protein Gene Product 9.5
Published on: April 26, 2019
Faecal calprotectin in children with chronic gastrointestinal symptoms
Alan Bremner1, Sohere Roked, Rebecca Robinson
1Southampton General Hospital, Southampton, United Kingdom. ronaldbremner@hotmail.com
Insights
Faecal calprotectin is a useful marker for identifying inflammatory bowel disease in children with chronic intestinal symptoms. Elevated levels suggest an organic bowel disorder, necessitating further investigation.
Area of Science:
- Pediatric Gastroenterology
- Clinical Chemistry
- Biomarker Research
Background:
- Inflammatory bowel disease (IBD) diagnosis in children presents challenges.
- Faecal calprotectin is a known indicator of intestinal inflammation.
Observation:
- This study evaluated faecal calprotectin levels in 100 children aged 5-17 with chronic intestinal symptoms.
- Tests were performed using a commercially available assay.
Findings:
- Faecal calprotectin levels were significantly higher in children with IBD compared to healthy children or those with functional constipation (p<0.0001).
- The test demonstrated 85% specificity for organic bowel disorders.
- Calprotectin correlated with C-reactive protein and disease activity in ulcerative colitis, but not Crohn's disease.
Implications:
- Raised faecal calprotectin in children with chronic intestinal symptoms warrants further diagnostic assessment for organic bowel disorders.
- While valuable, faecal calprotectin is not a definitive test for idiopathic inflammatory bowel disease.
Aims:
Faecal calprotectin, a neutrophil cytosolic protein, is raised in inflammatory bowel disease. We assessed this investigation in evaluating children with chronic intestinal symptoms.
Methods:
Stool samples from 100 children aged 5-17 years (referrals to the regional paediatric gastroenterology service) were tested using a commercially available kit.
Results:
Calprotectin was higher in inflammatory bowel disease than normal children (p<0.0001) or in those with functional constipation (p<0.0001). The overall specificity for organic bowel disorders was 85%. Calprotectin correlated with C-reactive protein in inflammatory bowel disease (p=0.001), and clinical disease activity in ulcerative colitis (p=0.017), but not with disease activity in Crohn's disease.
Conclusion:
Raised faecal calprotectin should prompt further assessment in children with chronic intestinal symptoms, since an organic bowel disorder is likely. However, calprotectin cannot be regarded as a specific test for idiopathic inflammatory bowel disease.
Related Concept Videos
Serum Laboratory Studies, Stool Test, Breath Test
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
